FDA Panel Votes Against Breast Cancer Drug

PITTSBURGH (KDKA) — For breast cancer that has spread to other parts of the body, some women take the drug Avastin.

A local grandmother is one of them, getting the IV treatment every three weeks.

So what does she think about the Food and Drug Administration considering revoking its approval?

“It almost makes you lose hope, then. If you’re taking something that’s going to help you, you think why are they taking it off you?” asks Marlene Dagen of Center Township.

The initial approval in 2008 was fast-tracked and based on a single study.

Since then, five randomized controlled trials of 3,500 patients showed no significant improvement in overall survival or quality of life. There’s also an increased risk of ruptured intestines, bleeding and death.

“Patients lived longer without their disease getting worse, but none of them showed that overall survival was actually better,” explains Dr. Jane Raymond, a breast cancer specialist at Allegheny General Hospital. “So the FDA and the expert panel is saying, ‘Well if you can’t show you can’t prolong survival, then the drug isn’t worth it.’”

About 17,000 American women take this medicine, which is a protein thought to stop blood vessel growth in tumors.

“Patients think, well, ‘This is my lifeline.’ On the other hand, there aren’t studies that prove that the Avastin was actually keeping them disease free,” Dr. Raymond continues. “So I always explain to them we don’t really have the information and that we’re doing that because everybody thought it might be helpful.”

Doctors could still prescribe Avastin without FDA approval, but insurance wouldn’t cover it. It can cost up to $100,000 a year.

If Avastin is no longer an option, women can still get chemo and hormones. Perhaps someday, with genetic testing of cancers, the people who would benefit most from the drug could be identified.

“I hope they find the appropriate place for Avastin, because I think there is a spot,” says Dr. Raymond.

More Health News
More Reports By Dr. Maria Simbra

KDKA On Facebook
KDKA On Twitter
Follow KDKA Personalities

More from Dr. Maria Simbra
  • genomega1

    What did people think was going to happen under Obamacare?
    You now have a price tag on your life, if you are wealthy you will get the care that you need. The rest of us are expendable. Doctors swear by Avastin and will continue to prescribe the drug. This is just the beginning of a long list of cuts coming.

  • A.Bunker

    A look into the future if obamacare is implemented as planned. A panel of ‘experts’ determining which drugs are effective and which drugs aren’t based on cost alone. Comparative Effectiveness I think it is called and it is nothing short of the death panels that Sarah Palin warned us about. genomega1 is exactly right.

  • http://implantsbreastenlargement.com/cancer-breast.html cancer breast -Breast Blog Search

    […] According to American cancer society, about 1.3 million new breast cancer cases are diagnosed on anFDA Panel Votes Against Breast Cancer Drug « CBS Pittsburgh7 hours ago by angelakdkaFive randomized controlled trials of 3500 patients showed no significant […]

blog comments powered by Disqus
Bringing You The Best in Sports Talk Radio
Download And Win Today!

Listen Live